CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Stock Payable [Member]	Subscription Receivable [Member]	Accumulated Deficit [Member]	Total
Beginning balance at Mar. 31, 2020	$ 3,400	$ 45,585	$ 54,094,848	$ 1,000,000		$ (53,521,700)	$ 1,622,133
Beginning balance (in shares) at Mar. 31, 2020	3,400,000	45,585,592
Preferred Stock Conversion	$ (3,400)	$ 3,400
Preferred Stock Conversion (in shares)	(3,400,000)	3,400,000
Common shares issued in connection with offerings		$ 23,717	15,875,828	$ (1,000,000)			14,899,545
Common shares issued in connection with offerings (Shares)		23,717,818
Common shares issued upon exercise of warrants		$ 13,294	7,101,592				7,114,886
Common shares issued upon exercise of warrants (in shares)		13,293,728
Common shares issued to non-employees and employees		$ 1,046	1,254,251				1,255,297
Common shares issued to non-employees and employees (in shares)		1,045,801
Common shares issued to employees		$ 70	69,930				70,000
Common shares issued to employees (in shares)		70,000
Stock Option expense			1,621,199				1,621,199
Stock option exercise		$ 352	61,128				$ 61,480
Stock option exercise (in shares)		352,239					506,000
Restricted Stock expense			778,966				$ 778,966
Net (loss)						(16,409,520)	(16,409,520)
Ending balance at Mar. 31, 2021		$ 87,464	80,857,742			(69,931,220)	11,013,986
Ending balance (in shares) at Mar. 31, 2021		87,465,178
Preferred stock issuance	$ 6,681		2,220,350				2,227,031
Preferred stock issuance (in shares)	6,681,000
Preferred Stock Conversion	$ (2,227)	$ 2,227
Preferred Stock Conversion (in shares)	(2,227,030)	2,227,030
Common shares issued in connection with offerings		$ 5,039	5,251,056		$ 62,338		5,193,707
Common shares issued in connection with offerings (Shares)		5,038,840
Common shares issued in connection with convertible note		$ 475	344,980				345,455
Common shares issued in connection with convertible note (in shares)		475,000
Beneficial conversion feature							1,524,750
Common shares issued upon exercise of warrants		$ 11,469	13,378,842				13,390,311
Common shares issued upon exercise of warrants (in shares)		11,467,820
Common shares issued to non-employees and employees		$ 227	368,192				368,419
Common shares issued to non-employees and employees (in shares)		226,636
Stock option exercise		$ 282	107,899				$ 108,181
Stock option exercise (in shares)		282,977					362,333
Stock option and RSU-related stock compensation expense and common shares issued upon conversion of RSU		$ 3,389	5,810,269				$ 5,813,658
Stock option and RSU-related stock compensation expense and common shares issued upon conversion of RSU (in shares)		3,388,331
Net (loss)						(39,584,360)	(39,584,360)
Ending balance at Mar. 31, 2022	$ 4,454	$ 110,572	$ 109,864,080		$ (62,338)	$ (109,515,580)	$ 401,138
Ending balance (in shares) at Mar. 31, 2022	4,453,970	110,571,812